Exscientia Secures $100M To Expand AI Drug Discovery Platform - | hitconsultant.net 2021/03/04 ...Exscientia, leading AI drug discovery company, today announced that it completed its $100 million Series C financing round, https://hitconsultant.net/2021/03/04/exscientia-ai-drug-discovery-platform-funding/
Exscientia and Sanofi to develop AI-driven medicines | ddw-online.com 2022/01/10 ... Andrew Hopkins, DPhil, CEO and founder of Exscientia, said: “Our AI-driven platform can be leveraged across drug discovery, ... https://www.ddw-online.com/exscientia-and-sanofi-to-develop-ai-driven-medicines-15156-202201/
Exscientia boosts AI platform with purchase of Kinetic Discovery | thepharmaletter.com 2018/11/15 ...Exscientia, an artificial intelligence specialist, says the purchase will boost its ability to create novel drug candidates by “seeding its ... https://www.thepharmaletter.com/article/exscientia-boosts-ai-platform-with-purchase-of-kinet...
Sanofi, Exscientia to develop AI-driven pipeline of precision ... | sciencebusiness.net 2022/01/07 ... ... success Agreement to utilize Exscientia's AI-based capabilities and ... These updates are republished press releases and communications ... https://sciencebusiness.net/network-updates/sanofi-exscientia-develop-ai-driven-pipeline-pre...
Exscientia Enters Strategic Drug Discovery Collaboration with GSK | prnewswire.com 2017/07/02 ... PRNewswire/ -- Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to ... https://www.prnewswire.com/news-releases/exscientia-enters-strategic-drug-discovery-collabor...
Sumitomo Dainippon Pharma and Exscientia achieve breakthrough ... | healthcareitnews.com 2020/01/31 ... Japanese giant Sumitomo Dainippon Pharma and Oxford-headquartered AI-driven drug discovery company Exscientia yesterday announced that they ... https://www.healthcareitnews.com/news/asia/sumitomo-dainippon-pharma-and-exscientia-achieve-...
Would you take a drug discovered by artificial intelligence? - Vox | vox.com 2020/01/31 ... An OCD drug created via AI will be tested on humans. ... The British startup Exscientia claims it has developed the first medication created ... https://www.vox.com/2020/1/31/21117102/artificial-intelligence-drug-discovery-exscientia
Exscientia creates first drug using AI | Pharmafile | pharmafile.com 2020/01/31 ...Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge ... https://www.pharmafile.com/news/539964/exscientia-creates-first-drug-using-ai
Exscientia announces multi-target, AI-driven drug discovery | ai-techpark.com 2021/05/20 ...Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced today that it has entered into a ... https://ai-techpark.com/exscientia-announces-multi-target-ai-driven-drug-discovery/
Exscientia acquires AI precision medicine company Allcyte | pharmaceuticalmanufacturer.media 2021/06/16 ... Pharmatech Exscientia is to acquire precision medicine company ... provide expanded cell culture media development capabilities and new cell ... https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-invest...